ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 23, 2021Century Therapeutics (NASDAQ: IPSC) today announced the closing of its initial public offering of 12,132,500 shares of its common stock at a public offering price of $20.00 per share -
Century Therapeutics Significantly Expands Capabilities
February 20, 2021Century Therapeutics, a cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced a significant expansion of its operational and laboratory space in Philadelphia, as well as progress on its ...
Pharma Sources Insight January 2025
